Susquehanna International Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,500
Closed -$20.8K 13033
2025
Q2
$20.8K Buy
+16,500
New +$20.4K ﹤0.01% 12324
2024
Q3
Sell
-8,180
Closed -$48.3K 12414
2024
Q2
$48.3K Buy
8,180
+240
+3% +$1.9K ﹤0.01% 11425
2024
Q1
$56.4K Buy
+7,940
New +$56.5K ﹤0.01% 11515
2022
Q4
Sell
-3,190
Closed -$43K 12937
2022
Q3
$43K Sell
3,190
-5,320
-63% -$81.7K ﹤0.01% 12293
2022
Q2
$139K Buy
8,510
+310
+4% +$5.13K ﹤0.01% 11120
2022
Q1
$187K Buy
+8,200
New +$147K ﹤0.01% 11311
2021
Q4
Sell
-4,150
Closed -$244K 13435
2021
Q3
$244K Buy
+4,150
New +$301K ﹤0.01% 11054

Other funds holding HOOK

Susquehanna International Group's HOOK Position: Q3 2025 in Review

Susquehanna International Group sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 37,265 shares — an estimated $46.8K sold.

Susquehanna International Group first reported a position in HOOK in Q3 2020 and held it in 13 quarters. The position peaked at $609K in Q2 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Susquehanna International Group reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 37,265 HOOKIPA Pharma shares in Q3 2025, an estimated $46.8K.
  • Susquehanna International Group first reported a position in HOOKIPA Pharma in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's HOOKIPA Pharma position peaked at $609K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.